Note 14 - Stock-based Compensation - Summary of RSU Activity (Details) - shares |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Nov. 30, 2023 |
Nov. 30, 2022 |
|||||||
| Forfeited, non-options (in shares) | (107,750) | (26,000) | ||||||
| Restricted Stock Units (RSUs) [Member] | ||||||||
| Outstanding, non-options (in shares) | 1,314,909 | [1] | 1,594,120 | |||||
| Granted, non-options (in shares) | 102,720 | 536,805 | ||||||
| Settled, non-options (in shares) | (213,636) | (12,266) | ||||||
| Cancelled, non-options (in shares) | 0 | (778,750) | ||||||
| Forfeited, non-options (in shares) | (625,743) | (25,000) | ||||||
| Outstanding, non-options (in shares) | 578,250 | [2] | 1,314,909 | [1] | ||||
| ||||||||
| X | ||||||||||
- Definition The number of equity instruments settled under share based compensation arrangement. No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|